Vancoresmycin, a process for its production and its use as a pharmaceutical

Vancoresmycin, a compound of the molecular formula C71H126N2O21, obtained by cultivation of the microorganism Amycolatopsis strain HIL-006734 (DSM 12216), or a mutant thereof which produces Vancoresmycin, under aerobic conditions in a nutrient medium containing sources of carbon and nitrogen,

• followed by isolation, and
• purification,
• or a pharmaceutically acceptable salt of Vancoresmycin, a derivative of Vancoresmycin, a stereoisomer of Vancoresmycin, a stereoisomer of a pharmaceutically acceptable salt of Vancoresmycin, a stereoisomer of a derivative of Vancoresmycin, a tautomer of Vancoresmycin, a tautomer of a pharmaceutically acceptable salt of Vancoresmycin, or a tautomer of a derivative of Vancoresmycin.